Alison Lawton Senior Vice President; General Manager, Biosurgery Alison Lawton joined Genzyme in 1991 as an international regulatory affairs specialist. As head of Genzyme Biosurgery, Ms. Lawton is responsible for our global orthopedics, biosurgical specialty (BSS) and cell therapy and regenerative medicine (CT&RM) businesses. The orthopedic business includes the Synvisc and Jonexa franchises; the BSS business consists of Seprafilm; and the CT&RM products include the autologous cell therapies Carticel, MACI and Epicel. Prior to this role, Ms. Lawton oversaw Global Market Access at Genzyme, which included Regulatory Affairs, Global Health Outcomes and Strategic Pricing, Global Public Policy and Global Product Safety & Risk Management. Before coming to Genzyme, Ms. Lawton worked for seven years at Parke-Davis in the U.K. She has a B.S. from the University of London.